Jace Yawnick was diagnosed with primary mediastinal B-cell non-Hodgkin lymphoma in Jan. 2024 at 25 years old. However, Yawnick's first onset of symptoms dates back to Aug. 2023, when he was ...

Cancer survivor Zoe Plastiras hopes her message provides some reassurance by highlighting advances in cancer treatment.

A retrospective study of the incidence of these events in a large cohort of Hodgkin lymphoma survivors has now confirmed that patients who received radiation to the neck and mediastinum have a ...

Three subtypes have been identified by gene-expression studies; germinal center (GC) DLBCL, non-GC DLBCL, and mediastinal large B-cell lymphoma. GC and non-GC DLBCL differ with respect to the cell ...

Dan Evans, 19, from Newark in Nottinghamshire, described his huge relief ringing the "cancer-free bell" at the teenage cancer ...

Yescarta (axicabtagene ciloleucel) has been approved as a treatment for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma ...

A 19-year-old is celebrating being cancer-free – a year after he was told that there was no hope and to “go home and make memories with his family”.